Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. D-phe-cys-tyr-d-trp-lys-val-cys-trp-nh2
2. D-phenylalanyl-cysteinyl-tyrosyl-d-tryptophyl-lysyl-valyl-cysteinyl-tryptophanamide
3. Octastatin
4. Rc 160
5. Rc-160
6. Vapreotide
1. Vapreotide
2. 103222-11-3
3. Rc 160
4. Bmy 41606
5. L-tryptophanamide, D-phenylalanyl-l-cysteinyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl-l-cysteinyl-, Cyclic (2?7)-disulfide, Acetate (1:?);l-tryptophanamide, D-phenylalanyl-l-cysteinyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl-l-cysteinyl-, Cyclic (2?7)-disulfide, Acetate (1:?)
6. Rc-160 (vapreotide)
7. Rc-160
8. Vapreotide (usan/inn)
9. Gtpl2054
10. Schembl6369050
11. Bdbm82464
12. Bcp21232
13. Cas_71306
14. Mfcd30489723
15. Nsc_71306
16. Akos015896024
17. Ft-0652516
18. D06281
19. L001100
20. Sanvar Ir; Vapreotidum; Rc 160; Rc-160; Rc160
21. (4r,7s,10s,13r,16s,19r)-13-((1h-indol-3-yl)methyl)-n-((s)-1-amino-3-(1h-indol-3-yl)-1-oxopropan-2-yl)-19-((r)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
22. (4r,7s,10s,13s,16s,19r)-10-(4-aminobutyl)-n-[(2r)-1-amino-3-(1h-indol-3-yl)-1-oxopropan-2-yl]-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
| Molecular Weight | 1131.4 g/mol |
|---|---|
| Molecular Formula | C57H70N12O9S2 |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 13 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 18 |
| Exact Mass | 1130.48301420 g/mol |
| Monoisotopic Mass | 1130.48301420 g/mol |
| Topological Polar Surface Area | 401 Ų |
| Heavy Atom Count | 80 |
| Formal Charge | 0 |
| Complexity | 2080 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 8 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
H - Systemic hormonal preparations, excl. sex hormones and insulins
H01 - Pituitary and hypothalamic hormones and analogues
H01C - Hypothalamic hormones
H01CB - Somatostatin and analogues
H01CB04 - Vapreotide
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Vapreotide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vapreotide, including repackagers and relabelers. The FDA regulates Vapreotide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vapreotide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vapreotide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vapreotide supplier is an individual or a company that provides Vapreotide active pharmaceutical ingredient (API) or Vapreotide finished formulations upon request. The Vapreotide suppliers may include Vapreotide API manufacturers, exporters, distributors and traders.
click here to find a list of Vapreotide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vapreotide DMF (Drug Master File) is a document detailing the whole manufacturing process of Vapreotide active pharmaceutical ingredient (API) in detail. Different forms of Vapreotide DMFs exist exist since differing nations have different regulations, such as Vapreotide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vapreotide DMF submitted to regulatory agencies in the US is known as a USDMF. Vapreotide USDMF includes data on Vapreotide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vapreotide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vapreotide suppliers with USDMF on PharmaCompass.
Vapreotide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vapreotide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vapreotide GMP manufacturer or Vapreotide GMP API supplier for your needs.
A Vapreotide CoA (Certificate of Analysis) is a formal document that attests to Vapreotide's compliance with Vapreotide specifications and serves as a tool for batch-level quality control.
Vapreotide CoA mostly includes findings from lab analyses of a specific batch. For each Vapreotide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vapreotide may be tested according to a variety of international standards, such as European Pharmacopoeia (Vapreotide EP), Vapreotide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vapreotide USP).
LOOKING FOR A SUPPLIER?
